Acute immune signatures and their legacies in severe acute respiratory syndrome coronavirus-2 infected cancer patients
Acute immune signatures and their legacies in severe acute respiratory syndrome coronavirus-2 infected cancer patients
Acute immune signatures and their legacies in severe acute respiratory syndrome coronavirus-2 infected cancer patients
Acute immune signatures and their legacies in severe acute respiratory syndrome coronavirus-2 infected cancer patients
Acute immune signatures and their legacies in severe acute respiratory syndrome coronavirus-2 infected cancer patients
Acute immune signatures and their legacies in severe acute respiratory syndrome coronavirus-2 infected cancer patients
Acute immune signatures and their legacies in severe acute respiratory syndrome coronavirus-2 infected cancer patients
Acute immune signatures and their legacies in severe acute respiratory syndrome coronavirus-2 infected cancer patients
Acute immune signatures and their legacies in severe acute respiratory syndrome coronavirus-2 infected cancer patients
Acute immune signatures and their legacies in severe acute respiratory syndrome coronavirus-2 infected cancer patients
Acute immune signatures and their legacies in severe acute respiratory syndrome coronavirus-2 infected cancer patients
Acute immune signatures and their legacies in severe acute respiratory syndrome coronavirus-2 infected cancer patients
Acute immune signatures and their legacies in severe acute respiratory syndrome coronavirus-2 infected cancer patients
Acute immune signatures and their legacies in severe acute respiratory syndrome coronavirus-2 infected cancer patients
Acute immune signatures and their legacies in severe acute respiratory syndrome coronavirus-2 infected cancer patients
Acute immune signatures and their legacies in severe acute respiratory syndrome coronavirus-2 infected cancer patients

Cancer and coronavirus

Cancer patients who contract and recover from Coronavirus-2 exhibit long-term immune system weaknesses, depending on the type of cancer.

Acute immune signatures and their legacies in severe acute respiratory syndrome coronavirus-2 infected cancer patients

Cancer Cell 39, 261 (2021)

S. A. Jawad, L. Baú, T. Alaguthurai, I. del Molino del Barrio, A. G. Laing, T. S. Hayday, L. Monin, M. Muneoz-Ruiz, L. McDonald, I. F. Quijorna, D. McKenzie, R. Davis, A. Lorenc, J. Nuo En Chan, S. Ryan, E. Bugallo-Blanco, R. Yorke, S. Kamdar, M. Fish, I. Zlatareva, P. Vantourout, A. Jennings, S. Gee, K. Doores, K. Bailey, S. Hazell, J. De Naurois, Ch. Moss, B. Russell, A. A. Khan, M. Rowley, R. Benjamin, D. Enting, D. Alrifai, Y. Wu, Y. Zhou

Cancer Cell 39, 261 (2021)

S. A. Jawad, L. Baú, T. Alaguthurai, I. del Molino del Barrio, A. G. Laing, T. S. Hayday, L. Monin, M. Muneoz-Ruiz, L. McDonald, I. F. Quijorna, D. McKenzie, R. Davis, A. Lorenc, J. Nuo En Chan, S. Ryan, E. Bugallo-Blanco, R. Yorke, S. Kamdar, M. Fish, I. Zlatareva, P. Vantourout, A. Jennings, S. Gee, K. Doores, K. Bailey, S. Hazell, J. De Naurois, Ch. Moss, B. Russell, A. A. Khan, M. Rowley, R. Benjamin, D. Enting, D. Alrifai, Y. Wu, Y. Zhou